Skip to content

Morphine Versus Morphine-promethazine Combination for Acute Low Back Pain Relief in the Adult Emergency Department

Pharmacological Anxiolysis With Promethazine as an Adjunctive Therapy for Acute Low Back Pain in the Adult Emergency Department

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01129934
Enrollment
200
Registered
2010-05-25
Start date
2010-05-31
Completion date
2013-01-31
Last updated
2010-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

Low Back Pain,, Emergency medicine,, Promethazine,, Morphine,, Pain relief

Brief summary

Acute low back pain is a common cause for emergency department visits. Controversy remains regarding the optimal medication for acute low back pain relief. The investigators hypothesized that administration of pharmacological anxiolysis in addition to analgesia will improve pain relief and patient management in the emergency department.

Detailed description

Acute low back pain is a common problem in the emergency department and pain relief is usually the first step in patients' management. Numerous medication options are available for acute LBP relief,each class of medication has its associated benefits and harms.Controversy remains regarding the optimal analgesic treatment.Anxiety has been found to be a predictive factor of pain intensity in patients with acute low back pain and anxiolysis by non-pharmacological measures has been shown to have a positive effect on pain management in the ED setting. Promethazine is a first-generation H1 receptor antagonist of the phenothiazine chemical class used commonly as an antihistamine antiemetic. It has a strong anxiolytic-sedative effect and its safety and efficacy in managing anxiety related to medical procedures is well documented.It may be reasonable to assume that pharmacological anxiolysis with promethazine may assist in alleviation of acute pain in the strenuous environment of the ED.

Interventions

DRUGMorphine-Promethazine

administration of intravenous morphine 0.1mg/kg and promethazine 12.5 mg in a 500 Ml 0.9% saline

DRUGmorphine

Administration of intravenous morphine 0.1 mg/kg

Sponsors

Tel-Aviv Sourasky Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. An indication for opioid analgesia based in the ED (i.e. severe pain \> 70mm on a 100mm VAS) 2. Age between 18-65 years 3. American Society of Anesthesiologists (ASA) score of 1 or 2, and no preexisting glaucoma, cardiac arrhythmia or pulmonary disease 4. Systolic blood pressure higher than 90 mmHg on admission 5. Willingness and ability to provide an informed consent 6. No known hypersensitivity to the medication used.

Exclusion criteria

1. Pregnant women 2. Patients who can not be under adult supervision following discharge from the emergency department.

Design outcomes

Primary

MeasureTime frameDescription
Pain reliefUp to 24 hours (before analgesia administration and on discharge from the ED or admission to the hospital)Pain scores before and after treatment will be assessed on a 100mm VAS. The difference will be regarded as pain relief.

Secondary

MeasureTime frameDescription
Ambulatory statusUp to 24 hours (before analgesia administration and on discharge from the ED or admission to the hospital)Most patients who suffer from acute LBP are in severe pain and are unable to ambulate. The ambulatory status of every patient (e.g., able to walk independently, using a can, wheelchair, laying down and unable to sit or stand up)will be recorded before and after treatment.

Countries

Israel

Contacts

Primary ContactOfir Uri, M.D
ofiruri@gmail.com972-52-4262285

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026